The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
Open accessAbstract
Cystic fibrosis (CF) is the most common lethal hereditary disorder with autosomal recessive heredity in caucasians. The majority of CF patients suffer from chronic respiratory infection with the opportunistic bacterial pathogen Pseudomonas aeruginosa. No consensus among clinicians has been reached so far concerning antibiotic treatment against P. aeruginosa in CF patients. Consensus answers to 24 important questions in this context, based on current evidence, are presented, given by a panel of 34 European experts. Questions addressed and answered are: The diagnosis of P. aeruginosa lung colonization in CF; The impact of P. aeruginosa on the clinical state of CF patients; The assessment of P. aeruginosa susceptibility against antibiotics and the importance of these results for the clinician; The use of monotherapy versus combination therapy; The development of microbial resistance; The achievement of optimal airway concentrations; The effects of subinhibitory concentrations of antibiotics on P. aeruginosa; Statements on the pharmacokinetics of antibiotics in CF patients; Recommendations for doses and dosing intervals and length of treatment regimens; and Toxic side effects due to repeated antibiotic therapy was addressed. The expert panel answered further questions on the use of fluoroquinolones in children with CF, on the administration of nebulized antibiotics and whether prevention of P. aeruginosa lung colonization is possible in CF using antibiotic therapy. Problems of antibiotic therapy at home and in the hospital were addressed, a consensus statement on regular maintenance treatment, or treatment on demand, was given and different routes of administration of antibiotics were recommended for different clinical situations. Finally, the factors which determine the choice of the antibiotic, the dosage, and the duration of the treatment in cystic fibrosis patients were addressed and the design of future antibiotic studies in the context of Pseudomonas aeruginosa lung infection in cystic fibrosis patients were recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,169
Nickel, J. C., Ruseska, I., Wright, J. B., & Costerton, J. W. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.4.619 · Cited by 889
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
Shak, S., Capon, D. J., Hellmiss, R., Marsters, S. A., & Baker, C. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9188 · Cited by 707
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
Valerius, N. H., Koch, C., & Høiby, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)91446-2 · Cited by 475
Self-citationFrederiksen, B., Koch, C., & Høiby, N. (1997) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o · Cited by 473
Self-citationLower Airway Inflammation in Infants and Young Children with Cystic Fibrosis
ARMSTRONG, D. S., GRIMWOOD, K., CARLIN, J. B., CARZINO, R., GUTIÈRREZ, J. P., HULL, J., OLINSKY, A., PHELAN, E. M., ROBERTSON, C. F., & PHELAN, P. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.96-11058 · Cited by 467
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Dorkin, H. L., Eisenberg, J. D., Gibson, R. L., Harwood, I. R., Kravitz, R. M., Schidlow, D. V., Wilmott, R. W., Astley, S. J., McBurnie, M. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282403 · Cited by 458
Determinants of Mortality from Cystic Fibrosis in Canada, 1970-1989
Corey, M., & Farewell, V. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008664 · Cited by 360
Jensen, T., Pedersen, S. S., Garne, S., Heilmann, C., Høiby, N., & Koch, C. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.6.831 · Cited by 314
Self-citationKerem, E., Corey, M., Gold, R., & Levison, H. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82653-8 · Cited by 306
Burns, J. L., Van Dalfsen, J. M., Shawar, R. M., Otto, K. L., Garber, R. L., Quan, J. M., Montgomery, A. B., Albers, G. M., Ramsey, B. W., & Smith, A. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314727 · Cited by 289
Long-term azithromycin may improve lung function in children with cystic fibrosis
Jaffé, A., Francis, J., Rosenthal, M., & Bush, A. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78360-4 · Cited by 276
Powell, S. H., Thompson, W. L., Luthe, M. A., Stern, R. C., Grossniklaus, D. A., Bloxham, D. D., Groden, D. L., Jacobs, M. R., DiScenna, A. O., Cash, H. A., et al. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.5.918 · Cited by 272
Regelmann, W. E., Elliott, G. R., Warwick, W. J., & Clawson, C. C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.4_pt_1.914 · Cited by 262
Quantitative Deposition of Aerosolized Gentamicin in Cystic Fibrosis
Ilowite, J. S., Gorvoy, J. D., & Smaldone, G. C. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.6.1445 · Cited by 247
Frederiksen, B., Lanng, S., Koch, C., & Hølby, N. (1996) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199603)21:3<153::aid-ppul1>3.0.co;2-r · Cited by 247
Small-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis
Rohde, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598644 · Cited by 238
SZAFF, M., HØIBY, N., & FLENSBORG, E. W. (1983) · Acta Paediatrica · doi:10.1111/j.1651-2227.1983.tb09789.x · Cited by 233
Self-citationMICROBIOLOGY OF LUNG INFECTIONS IN CYSTIC FIBROSIS PATIENTS
HØIBY, N. (1982) · Acta Paediatrica · doi:10.1111/j.1651-2227.1982.tb09640.x · Cited by 226
Self-citationQuinolone Arthropathy in Animals Versus Children
Burkhardt, J. E., Walterspiel, J. N., & Schaad, U. B. (1997) · Clinical Infectious Diseases · doi:10.1086/516119 · Cited by 219
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.
Mendelman, P. M., Smith, A. L., Lévy, J., Weber, A., Ramsey, B. W., & Davis, R. L. (1985) · PubMed · doi:10.1164/arrd.1985.132.4.761 · Cited by 216
NEBULISED COLOMYCIN FOR EARLY PSEUDOMONAS COLONISATION IN CYSTIC FIBROSIS
Littlewood, J. M., Miller, M. G., Ghoneim, A. T., & Ramsden, C. H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92222-6 · Cited by 203
Wiesemann, H. G., Steinkamp, G., Ratjen, F., Bauernfeind, A., Przyklenk, B., Döring, G., & von der Hardt, H. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199802)25:2<88::aid-ppul3>3.0.co;2-j · Cited by 200
Self-citationRamsey, B. W., & Boat, T. F. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70301-9 · Cited by 200
Penetration of Antibiotics into Respiratory Secretions
Pennington, J. E. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.1.67 · Cited by 192
Antibiotic Pharmacokinetics in Cystic Fibrosis: Differences and Clinical Significance
de Groot, R., & Smith, A. L. (1987) · Clinical Pharmacokinetics · doi:10.2165/00003088-198713040-00002 · Cited by 167
Ramsey, B. W., Wentz, K. R., Smith, A. L., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.2.331 · Cited by 154
MacLusky, I., Gold, R., Corey, M. L., & Levison, H. (1989) · Pediatric Pulmonology · doi:10.1002/ppul.1950070110 · Cited by 148
Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis
Smith, A. L., Ramsey, B. W., Hedges, D. L., Hack, B. D., Williams‐Warren, J., Weber, A., Gore, E. J., & Redding, G. J. (1989) · Pediatric Pulmonology · doi:10.1002/ppul.1950070413 · Cited by 147
Smith, A. L., Doershuk, C. F., Goldmann, D. A., Gore, E., Hilman, B. C., Marks, M. I., Moss, R. B., Ramsey, B. W., Redding, G. J., Rubio, T. T., et al. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70197-6 · Cited by 140
Inhalation of antibiotics in cystic fibrosis
Touw, D. J., Brimicombe, R., Hodson, M. E., Heijerman, H. G. M., & Bakker, W. M. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08091594 · Cited by 139
Self-citationUse of fluoroquinolones in pediatrics
Schaad, U. B., Salam, M. A., Aujard, Y., Dagan, R., Green, S. D. R., Peltola, H., Rubio, T. T., Smith, A. L., & Adam, D. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199501000-00001 · Cited by 139
Wolter, J. M., Bowler, S., Nolan, P., & McCormack, J. G. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10040896 · Cited by 138
Conway, S. P., Pond, M. N., Watson, A., Etherington, C., Robey, H. L., & Goldman, M. H. (1997) · Thorax · doi:10.1136/thx.52.11.987 · Cited by 136
Self-citationLongitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis
Döring, G., & Høiby, N. (1983) · Infection and Immunity · doi:10.1128/iai.42.1.197-201.1983 · Cited by 131
Self-citationShawar, R. M., MacLeod, D. L., Garber, R. L., Burns, J. L., Stapp, J. R., Clausen, C. R., & Tanaka, S. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2877 · Cited by 129
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period.
Weaver, L. T., Green, M. R., Nicholson, K., Mills, J. L., Heeley, M. E., Kuzemko, J. A., Austin, S., Gregory, G. A., Dux, A., & Davis, J. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.70.2.84 · Cited by 127
Hodson, M., Butland, R. J. A., Roberts, C. M., Smith, M. J., & Batten, J. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90062-6 · Cited by 120
Self-citationMacromolecular mechanisms of sputum inhibition of tobramycin activity
Hunt, B. E., Weber, A., Berger, A., Ramsey, B. W., & Smith, A. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.34 · Cited by 120
Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.
Høiby, N., & Koch, C. (1990) · Thorax · doi:10.1136/thx.45.11.881 · Cited by 120
Self-citationEisenberg, J. D., PEPE, M. S., PEPE, M. S., Vasiliev, M., Montgomery, A. B., Smith, A. L., & Ramsey, B. W. (1997) · CHEST Journal · doi:10.1378/chest.111.4.955 · Cited by 111
Mukhopadhyay, S., Singh, M., Cater, J. I., Ogston, S., Franklin, M. E., & Olver, R. E. (1996) · Thorax · doi:10.1136/thx.51.4.364 · Cited by 111
Stead, R. J., Hodson, M. E., & Batten, J. C. (1987) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(87)90161-6 · Cited by 109
Self-citationMucoid Pseudomonas aeruginosa Resists Nonopsonic Phagocytosis by Human Neutrophils and Macrophages
Cabral, D. A., Loh, B. A., & Speert, D. P. (1987) · Pediatric Research · doi:10.1203/00006450-198710000-00013 · Cited by 106
Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis.
Barclay, M. L., Begg, E. J., Chambers, S. T., Thornley, P., Pattemore, P., & Grimwood, K. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.6.1155 · Cited by 105
Schaad, U. B., Wedgwood, J., Suter, S., & Kraemer, R. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80130-0 · Cited by 99
STEPHENS, D., GAREY, N., Isles, A. F., Levison, H., & Gold, R. (1983) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198305000-00007 · Cited by 98
Nebulized gentamicin in children and adolescents with cystic fibrosis
KUN, P., Landau, L. I., & Phelan, P. D. (1984) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1984.tb00035.x · Cited by 97
Vinks, A. A. T. M. M. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.125 · Cited by 95
Ciofu, O., Giwercman, B., Pedersen, S. S., & Høiby, N. (1994) · PubMed · Cited by 94
Self-citationPseudomonas aeruginosa. The Organism, Diseases it Causes and Their Treatment
(1981) · Postgraduate Medical Journal · doi:10.1136/pgmj.57.667.339-c · Cited by 86
Pharmacokinetics of ciprofloxacin in cystic fibrosis
Davis, R. L., Koup, J. R., Williams‐Warren, J., et al. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.6.915 · Cited by 85
Dodd, M. E., Abbott, J., Maddison, J., Moorcroft, A. J., & Webb, A. K. (1997) · Thorax · doi:10.1136/thx.52.7.656 · Cited by 84
Gold, R., Carpenter, S., Heurter, H., Corey, M. L., & Levison, H. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80217-2 · Cited by 78
Warner, J. O. (1992) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072584 · Cited by 77
Primary adrenocortical nodular dysplasia, a distinct subtype of cushing's syndrome
Cugini, P., Letizia, C., Palma, L. D., et al. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90417-7 · Cited by 75
Gold, R., OVERMEYER, A., KNIE, B., Fleming, P. C., & Levison, H. (1985) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198503000-00012 · Cited by 74
Cystic fibrosis: A review of pulmonary infections and interventions
Thomassen, M. J., Oemko, C. A., & Doershuk, C. F. (1987) · Pediatric Pulmonology · doi:10.1002/ppul.1950030510 · Cited by 72
Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis
Pedersen, S. S., Jensen, T. G., Osterhammel, D., & Osterhammel, P. A. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.4.594 · Cited by 71
RICHARD, D. A., Nousia‐Arvanitakis, S., Sollich, V., et al. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199706000-00007 · Cited by 67
Home nebulizer use among patients with cystic fibrosis
Rosenfeld, M., Emerson, J., Astley, S. J., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70497-4 · Cited by 66
Cantin, A. M., & Woods, D. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116196 · Cited by 66
Ilowite, J. S., Smaldone, G. C., Perry, R. J., Bennett, W. D., & Foster, W. M. (1989) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.1989.9935893 · Cited by 62
Ghani, M., & Soothill, J. S. (1997) · Canadian Journal of Microbiology · doi:10.1139/m97-144 · Cited by 62
Laube, B. L., Links, J. M., LaFrance, N. D., et al. (1989) · CHEST Journal · doi:10.1378/chest.95.4.822 · Cited by 61
Pharmacokinetics of Drugs in Cystic Fibrosis
Spino, M. (1990) · Humana Press eBooks · doi:10.1007/978-1-4612-0475-6_11 · Cited by 56
Inhaled antibiotics in cystic fibrosis: Is there a therapeutic effect?
MacLusky, I., Levison, H., Gold, R., et al. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80758-2 · Cited by 56
Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis
Smith, M. J., White, L. O., Bowyer, H., Willis, J. V., Hodson, M. E., & Batten, J. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.614 · Cited by 55
Self-citationBronchial response to nebulized antibiotics in children with cystic fibrosis
Chua, H., Collis, G., & Souëf, P. N. L. (1990) · European Respiratory Journal · doi:10.1183/09031936.93.03101114 · Cited by 54
Ecology and Epidemiology of Pseudomonas aeruginosa
Botzenhart, K., & Döring, G. (1993) · Infectious Agents and Pathogenesis · doi:10.1007/978-1-4615-3036-7_1 · Cited by 53
Self-citationPermin, H., Koch, C., Heiby, N., et al. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.suppl_a.313 · Cited by 53
Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients
Kerem, E., Corey, M., Stein, R. T., et al. (1990) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199007000-00008 · Cited by 53
Nikolaizik, W. H., Jenni-Galović, V., & Schöni, M. H. (1996) · European Journal of Pediatrics · doi:10.1007/bf01957914 · Cited by 48
Lévy, J. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80755-7 · Cited by 47
Antibacterial Therapy in Cystic Fibrosis
Michel, B. C. (1988) · CHEST Journal · doi:10.1378/chest.94.2_supplement.129s · Cited by 32
Klinger, J. D., & Aronoff, S. C. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.6.679 · Cited by 29
Home Treatment of Pulmonary Infections in Cystic Fibrosis
Kuzemko, J. A. (1988) · CHEST Journal · doi:10.1378/chest.94.2_supplement.162s · Cited by 25
- Epidemiology of cystic fibrosis
MacNeill, S. (2015) · CRC Press eBooks · doi:10.1201/b18629-6 · Cited by 24
den Hollander, J. G., Mouton, J. W., van Goor, M. P., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.784 · Cited by 22
Wolter, J. M., Bowler, S., & McCormack, J. G. (1999) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1999.tb01583.x · Cited by 20
Stern, R. C. (1996) · Pediatric Pulmonology · doi:10.1002/1099-0496(199603)21:3<151::aid-ppul1950210303>3.0.co;2-w · Cited by 11
Cited by
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Self-citationPathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Metadata
- Authors
- Döring, G., Conway, S. P., Heijerman, H. G. M., Hodson, M. E., Høiby, N., Smyth, A., Touw, D. J., & the Consensus Committee, F.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2000-10
- Volume
- 16
- Issue
- 4
- Pages
- 749
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2155069031
- Cited by
- 620
- References
- 84
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.